Journal of Iranian Medical Council

Journal of Iranian Medical Council

Studies on Artificial Intelligence (AI) Techniques for Diabetes Diagnosis Using Facial Features

Document Type : Narrative Review

Authors
Department of Rheumatology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract
Diabetes Mellitus (DM) stands as one of the most widespread non-infectious diseases globally. Although diagnosis of diabetes is possible with the fasting plasma glucose test after 12-hour fast, once diabetes is diagnosed, it cannot be reversed. Therefore, it is crucial to identify early indicators for predicting diabetes. 
Presently, DM can be discerned through various methods involving the analysis of human facial features. One method for facial recognition in diabetes relies on experimental evidence, with its accuracy contingent on the skill and expertise of the physician. 
Another approach involves diagnosis based on facial morphological features. These morphological changes may be attributed to oxidative stress, damage of blood vessels and collagen, edema and craniofacial abnormalities stemming from hyperglycemia. While cephalometric analysis remains the gold standard for diagnosing skeletal craniofacial morphology, it is a costly and technique-sensitive procedure. 
Facial recognition based on Artificial Intelligence (AI) has proven to be a valuable tool in the diagnosis and screening of diabetes. Its combination of simplicity, accuracy, and cost-effectiveness makes it a promising addition to the healthcare landscape, ultimately contributing to advancements in pre-clinical diagnosis and leading to enhanced patient outcomes. 
Given the rapid global increase in diabetes, the importance of early detection of diabetes and the limited information about the role of facial recognition in this regard, this study assesses diabetes through facial features using AI approaches.

Keywords

Subjects


Abstract
Diabetes Mellitus (DM) stands as one of the most widespread non-infectious diseases globally. Although diagnosis of diabetes is possible with the fasting plasma glucose test after 12-hour fast, once diabetes is diagnosed, it cannot be reversed. Therefore, it is crucial to identify early indicators for predicting diabetes. 
Presently, DM can be discerned through various methods involving the analysis of human facial features. One method for facial recognition in diabetes relies on experimental evidence, with its accuracy contingent on the skill and expertise of the physician. 
Another approach involves diagnosis based on facial morphological features. These morphological changes may be attributed to oxidative stress, damage of blood vessels and collagen, edema and craniofacial abnormalities stemming from hyperglycemia. While cephalometric analysis remains the gold standard for diagnosing skeletal craniofacial morphology, it is a costly and technique-sensitive procedure. 
Facial recognition based on Artificial Intelligence (AI) has proven to be a valuable tool in the diagnosis and screening of diabetes. Its combination of simplicity, accuracy, and cost-effectiveness makes it a promising addition to the healthcare landscape, ultimately contributing to advancements in pre-clinical diagnosis and leading to enhanced patient outcomes. 
Given the rapid global increase in diabetes, the importance of early detection of diabetes and the limited information about the role of facial recognition in this regard, this study assesses diabetes through facial features using AI approaches.
Keywords: Artificial intelligence, Diabetes mellitus, Facial recognition, Oxidative Stress

 

Introduction
The most prevalent non-infectious disease in the world is Diabetes Mellitus (DM) (1-8). According to the World Health Organization, 171 million individuals worldwide have DM. By 2030, this number is projected to rise to 366 million (9), positioning the condition as one of the leading global causes of mortality, disability, and economic hardship. Diabetes develops when the body cannot adequately utilize or produce sufficient amounts of insulin, causing glucose in the blood to remain unable to enter cells for conversion into energy (10-19). This results in the onset of diabetic symptoms (20-27). Various factors such as obesity, genetics, race and ethnicity, age, medical history, smoking, nutrition, alcohol usage, and stress play a significant role in its development (27-39).
Early identification of diabetes poses a considerable challenge, and once it is detected, the condition cannot be reversed. Therefore, timely recognition of diabetes is vital to enable interventions that can delay or prevent the onset of type 2 diabetes. On the other hand, identifying individuals with prediabetes can lead to improved blood sugar control, reduced risk of complications, decreased economic burden, and an enhanced quality of life (40). 
Various methods have been attempted to detect diabetes through blood and urine tests. Traditionally, the diagnosis of diabetes involves the Fasting Plasma Glucose (FPG) test, which requires a small blood sample from the patient after a 12-hour fasting period. This method is considered uncomfortable, invasive, time-consuming, and inconvenient. Urine tests for diabetes have also been conducted in hospitals, but they are time-consuming and relatively expensive, making them less efficient. Given these circumstances, there is a pressing need for innovative solutions that allow for easy, effective, and efficient diabetes detection (41).
The diagnosis of diabetes through facial features has the potential to serve as a cost-effective screening tool (42,43). Researchers have currently uncovered various methods for detecting DM by analyzing human facial features (43). Facial features result from the complex interplay of genetic information, bone structure, muscle composition, adipose tissue distribution, and other factors, all of which are in line with the pathogenesis of Type 2 Diabetes (T2DM) (44). 
With the rapid development of Artificial Intelligence (AI), face recognition has attracted attention due to its status as the main method of human identification when compared with other types of biometric methods. Therefore, AI plays a critical role in face recognition technology, enabling systems to identify and verify individuals based on their facial features. It is essential for early detection and diagnosis, offers a non-invasive method, and provides cost-effectiveness, efficiency, and accuracy (45). 
Face recognition technology, powered by sophisticated AI algorithms, leverages deep learning techniques, particularly Convolutional Neural Networks (CNNs), to enhance the precision and reliability of facial identification and verification. These AI-driven systems are capable of learning and recognizing intricate patterns and features in human faces, even in diverse conditions such as varying lighting, angles, and facial expressions. Research indicates that AI-based face recognition systems have surpassed traditional biometric methods, achieving higher accuracy rates and lower error margins (45,46).
In the healthcare, AI-driven face recognition technology plays a pivotal role in patient identification, ensuring accurate medical records and personalized treatment. It is also being explored for early diagnosis of genetic disorders by analyzing facial phenotypes, demonstrating the potential for innovative medical applications.
Given the rapid global increase in diabetes cases (46), it is imperative to identify pre-diabetic patients and individuals at higher risk for future diabetes development. With the potential of AI and facial recognition technology as non-invasive, cost-effective, and efficient alternatives for detecting diabetes, this study aims to improve early diagnosis and patient outcomes. Since there is limited information regarding the role of facial recognition in diabetes diagnosis, this research seeks to evaluate early detection of diabetes based on facial features using various AI approaches.

Facial recognition 
The human face is a distinct marker of individual bio-identity, providing valuable insights into factors such as age, gender, race, consciousness, emotional state, and health status. Due to its accessibility and cost-effectiveness, facial recognition has gained widespread acceptance as a dependable biometric method, surpassing fingerprint and iris recognition. It is worth emphasizing that many diseases exhibit internal structural and functional abnormalities, as well as distinct facial characteristics and deformities (45).
Automatic facial recognition technology appeared in the 1960s, and over time, it has evolved into a pivotal tool with a wide range of real-world applications, including security surveillance, identity verification, forensic science, law enforcement, etc. (47). Pioneering research into the utilization of facial recognition for disease diagnosis began in the early 2000s, with initial successes in the identification of genetic syndromes in children (48,49) and the detection of facial neuromuscular dysfunction (50) through knowledge-based approaches. Recently, facial recognition-based diagnosis has emerged as a highly promising and innovative field within interdisciplinary medical practice. 
Facial recognition enables effective screening in clinical practice, offering the potential for early diagnosis. Such an early detection proves highly advantageous for patients, facilitating prompt initiation of therapy and ongoing lifelong support. 
The facial recognition system is employed for the evaluation of endocrine and metabolic disorders, genetic and chromosomal anomalies, neuromuscular ailments, and various other categories of diseases.

Influential Factors on the Face of Diabetic Patients 
It seems that the main effects of diabetes on the face can be attributed to edema, oxidative stress, and craniofacial anomalies, damage of blood vessels and collagen. 

Edema
Edema, the excessive accumulation of body fluids in interstitial spaces or body cavities is visibly evident on the faces of diabetic individuals. Edema results in puffiness around the eyes, leading to the characteristic swollen or compressed appearance of the average facial shape in individuals with diabetes (10). 


Damage of blood vessels and collagen
Elevated glucose levels can have detrimental effects on blood vessels, leading to impaired circulation and reduced blood flow within the skin. This vascular damage can result in alterations to the skin’s protein structure, particularly collagen, which is impacted by the diminished blood flow. Changes in collagen levels can significantly influence the skin’s ability to heal its overall texture and appearance. Notably, these skin issues often serve as indicators of inadequate glycemic control. 
Therefore, in individuals with diabetes, hyperglycemia can lead to impaired microcirculation, which can manifest clinically as visible deformities in facial veins. Consequently, diabetes can contribute to the development of various facial skin conditions, such as vitiligo, rubeosis faciei, Bell’s palsy, and scleroderma (51).

Oxidative stress and impaired collagen production
Hyperglycemia can influence the activity of oxidases via both direct and indirect mechanisms, ultimately leading to the generation of oxidative stress. Mechanistically, oxidative stress stimulates collagen breakdown and inhibits collagen production. 
Oxidative stress and the presence of Reactive Oxygen Species (ROS) lead to an increase in the c-Jun/AP-1 transcription factor, multiple matrix metalloproteinases, and the degradation of collagen. Furthermore, oxidative stress and ROS contribute to the down-regulation of the TGF-β type II receptor and Smad3 proteins, resulting in impaired collagen production (52). 
In addition, Advanced Glycation End products (AGEs), which is formed more quickly when blood glucose levels are elevated, produce ROS (53) through their primary signaling receptor, the AGE-specific receptor (sometimes shortened to RAGE). This causes proliferative, inflammatory, thrombotic, and fibrotic responses in a range of cells. This data demonstrates the role of AGEs in aging- and diabetes-related illnesses such complications from diabetic vascular disease (54). As a result, AGEs play important roles in the etiology of problems associated with diabetes. 

Craniofacial Anomalies 
The development of the craniofacial complex is influenced by a combination of genetic and environmental factors. Hormones, nutrition, mechanical stresses, and various local growth factors serve as regulatory mechanisms governing the normal development of the face and head (55). 

Craniofacial Anomalies in Type 1 Diabetes
The peak growth period, which coincides with the onset of Type 1 Diabetes (T1DM) and during which approximately 60% of adult bone mass, including craniofacial bone, is acquired, has a significant impact on the process of bone formation. While the exact causes of T1DM are still unknown, it is essential to emphasize that understanding the disease’s progression and its effects on craniofacial development may lead to advancements in oral health practices. 
Investigating the alterations in craniofacial bone structure and the dynamics of bone formation under diabetic conditions is crucial for comprehending how diabetes influences various aspects of mandibular growth and bone quality (56(. A comparison of craniofacial skeletal parameters in individuals with T1DM and a control group revealed that T1DM patients exhibit underdevelopment in most craniofacial skeletal and soft tissue aspects when compared to the control group. Consequently, diabetic patients display reduced skeletal maturation and cephalometric parameters (56). 

Craniofacial anomalies in the fetus 
Maternal diabetes can induce systemic metabolic changes that impact nearly every organ system, with the craniofacial, central nervous, and cardiovascular systems being the most commonly affected. These deformities, collectively referred to as diabetic embryopathy, are believed to stem from abnormalities in neural crest cell growth and neurulation during the early stages of organogenesis, typically occurring within the first 8 weeks of human gestation. “Neurocristopathies” is a term used to describe problems related to cranial neural crest cell production, migration, or differentiation that result in craniofacial deformities. Depending on when harm occurs during cranial neural crest cell development, distinct morphologies become apparent. Pregnant women with pre-gestational diabetes have a three-to-five times higher risk of giving birth to infants with birth abnormalities compared to women without diabetes (57). The significant likelihood that mothers with either Type 1 or Type 2 diabetes will have children with diabetic embryopathy points to hyperglycemia and increased glucose uptake by the embryo through glucose transporters as the primary causative factors (58).

The Mechanism of Hyperglycemia effect on Neural Tube Defects
Elevated oxidative phosphorylation and generation of ROS, stemming from excessive glucose metabolism lead to an oxidative stress condition (59,60). One of the negative effects of excess ROS is that it can disrupt key signaling events during cellular differentiation, resulting in structural abnormalities (61). 
Hyperglycemia and epigenetic modifications can affect the pax3 downregulation, and TCOF1 down-regulation. Downregulation of TCOF1 (through intermediate signals (and pax3 down-regulation can lead to p53 activation. P53 activation via apoptosis and cell cycle arrest lead to neural tube defect. In addition, hyperglycemia via increased oxidative stress led to accumulation of DNA damage, p53 activation, cell cycle arrest, apoptosis, hypoplasia, neural tube defects (57).  

Diabetic facial recognition
Diabetic facial recognition can be achieved using various methods. Some of these methods are done with emphasis on AI Top of Form       

- Physical manifestations 
In patients with DM, symptoms such as dehydration, ketosis, dry skin, and reduced skin elasticity can occur (62), but in most cases of DM, physical manifestations may be typically absent. It means that not all diabetic cases have facial clues indicating metabolic/diabetic condition. 
Insulin-Dependent Diabetes Mellitus (IDDM) is also associated with increased glycosylation of skin collagen, which leads to the accumulation of rigid and less degradable collagen. Consequently, diabetic patients generally have thicker skin, especially on the face, compared to non-diabetic individuals. This increased skin thickness in diabetics may be a contributing factor to the less angular or rounder facial shape observed in these individuals.
The faces of diabetic patients often exhibit puffiness around the eyes, giving them a compressed appearance. General observations suggest that in male individuals with diabetes, there is a noticeable tapering towards the front of the face. On the other hand, females tend to have smaller nasal cavities and a gentler curvature just above the teeth. Notably, females typically lack a brow ridge, and their foreheads exhibit a more pronounced curvilinear shape (10).  

Morphological Disorder-Based Procedures Geometric morphometrics 
Geometric morphometrics serve as a robust visual statistical tool (55) for the quantitative analysis of biological shape, its variations, and their relationships with other biotic or abiotic factors.
In the realm of biomedical and biological research, the analysis of an organ or organism’s shape and size becomes more precise when utilizing landmarks. In the field of medicine, the geometrical properties of organs are intertwined with a variety of studies that rely on statistical analyses, employing qualitative and quantitative measures, particularly in the context of image analysis. In this approach, data is acquired through landmarks, whose points adhere to the rules of homology, signifying biological correspondence and ensuring reliable anatomical definitions. This homology among landmarks plays a pivotal role in securing a biologically interpretable outcome (58).
Geometric morphometrics have proven effective in identifying patterns associated with diseases, primarily through the description of facial shape. It can be instrumental in pinpointing specific health-related issues within the healthcare domain. Geometric morphometrics approaches are employed to explain the edema-related alterations on diabetes patients’ faces. Diabetic individuals using partial warps may exhibit characteristics like right-sided asymmetry or elongation, brow ridge drooping, facial compression towards the center, and downward skin folding around the eyes (10). However, traditional morphometric measures such as linear distances, angles, and ratios have limitations in accurately quantifying the intricate geometry of specific anatomical structures (60).

Cephalometry  
Cephalometry, introduced by Broadbent in 1931, ushered in a profound transformation in the diagnostic evaluation of facial forms and various craniofacial features. Lateral cephalograms, in particular, hold immense diagnostic and treatment planning significance. Linear and angular measure- ments obtained from lateral cephalograms play a pivotal role in the diagnosis and assessment of growth and developmental abnormalities. It is worth noting that while cephalometric analysis remains the gold standard for diagnosing skeletal craniofacial morphology in orthodontic clinical practice, it is an expensive and technique-sensitive procedure (63). 
The cephalometric analysis for both Juvenile diabetes and control groups was shown and compared by Mushayat et al (56). 
Moreover, cephalometry has general limitations (64).
- Cephalometry provides a two-dimensional view of a three-dimensional object, which can limit its accuracy.
- Landmark identification errors can occur, reducing the reliability of cephalometric analysis. Errors may arise during the tracing procedures.
- Assumptions play a significant role in cephalometric method: a) symmetry: analysis based on lateral projections assumes the absence of skeletal asymmetry in the patient. If asymmetry is present, the analysis results may be inaccurate. This can be mitigated by analyzing postero-anterior projections. b) Accurate occlusal and postural positioning is crucial for the cephalogram’s accuracy.
- Fallacy of False Precision: When multiple cephalograms of the same individual are taken and traced, the measurement of various angles may show a standard error of 1:5, indicating slight variations with each measurement.
- Neglecting Patient Variability: Cephalometric values should not be treated as fixed goals, as individual patient differences can influence the results.

Artificial Intelligence (AI)
Since its inception in the 1950s, AI has been deeply committed to understanding human problem-solving approaches and integrating or simulating these strategies within computer programs (65). 
AI is a branch of computer science that aims to create systems or methods that analyze information and allow the handling of complexity in a wide range of applications (in this case, diabetes management). Although the application of AI algorithms involves highly technical and specialized knowledge, this has not prevented AI from becoming an essential part of the technology industry and making contributions to major advances within the field (66).
AI-based automatic image recognition has the potential to identify image features for diagnosing and screening various diseases, demonstrating satisfactory performance in diagnosing certain diseases (46,47,67). AI has been widely applied in the analysis and identification of medical images, such as lung nodules, colon polyps, breast nodules, and ocular fundus (68). AI is a quickly growing field, and its applications to diabetes research are growing even more rapidly.
Moreover, AI-based facial recognition has recently played a crucial role in the diagnosis and screening of diseases characterized by facial phenotypes or changes (45,69). For instance, AI algorithms can detect subtle facial anomalies that may indicate genetic disorders, enabling early intervention and personalized treatment plans. This technology offers a non-invasive, efficient, and accurate method for medical professionals to enhance diagnostic processes and improve patient outcomes.
Overall, the integration of AI in medical image and facial recognition continues to revolutionize healthcare by providing advanced diagnostic tools, improving disease detection accuracy, and fostering innovative research avenues in fields like diabetes management and genetic disorder identification.
The most important AI-based facial recognition methods involve a combination of machine learning, computer vision, and deep learning algorithms. These techniques enable computers to identify and verify human faces from digital images or video frames:

Computer vision
Computer Vision is one of the most fascinating and challenging tasks in the field of AI. Computer Vision serves as a link between computer software and the visuals we see around us (70). A key goal of computer vision researchers is to create automated face recognition systems that can equal, and eventually surpass human performance. To this end, it is imperative that computational researchers know the key findings of experimental studies regarding face recognition by humans. These findings provide insights into the nature of cues that the human visual system relies upon for achieving its impressive performance and serve as the building blocks for efforts to artificially emulate these abilities (71).

Machine learning
Machine learning is a branch of computer science and has significantly advanced the field of facial recognition by enabling computers to learn and improve from ‎experience without being explicitly programmed for each specific task. It is closely related to computational statistics and mathematical optimization (45,72). Machine learning uses algorithms that can learn from and make predictions based on data (73). The primary types of learning algorithms include (74,75):
- Supervised Learning: Involves training the system on a labeled dataset, meaning the data includes both the input (e.g., facial images) and the correct output (e.g., the identity of the person).
- Unsupervised Learning: The system is trained on data without labeled responses, aiming to find hidden patterns or intrinsic structures in the input data. Techniques such as clustering can be used to group similar faces.
- Semi-Supervised Learning: Combines a small amount of labeled data with a large amount of unlabeled data during training. This approach is useful when acquiring a fully labeled dataset is expensive or time-consuming.
- Reinforcement Learning: The system learns by receiving rewards or penalties based on its actions, refining its strategy over time to maximize the cumulative reward ‎(6).‎
Machine learning methods can be applied in facial recognition systems to detect, align, recognize, verify, and identify individuals based on their facial features. Each step leverages specific machine learning techniques to achieve accurate and efficient facial recognition capabilities. In the following, a summary of each step in facial recognition is described (45,76,77). ‎
- Feature Extraction: Machine learning algorithms automatically identify and extract relevant features from facial images, such as the distance between the eyes, the shape of the cheekbones, and the contour of the lips. 
- Face Detection: The first step in facial recognition involves detecting the presence of faces in an image or video stream. Machine learning models are used to locate faces with high accuracy.
- Face Alignment: This step involves transforming the detected face to a canonical pose, which standardizes the face for further analysis. Techniques like facial landmark detection help in aligning the face by identifying the key points (e.g., corners of the eyes, tip of the nose).
- Face Recognition: The core task where machine learning models are used to match detected and aligned faces to a database of known faces.
- Face Verification and Identification 
Verification: Determines if two faces belong to the same person. This is typically a one-to-one matching task.
Identification: Identifies a person from a list of known individuals. This involves a one-to-many matching task, where the input face is compared against all faces in the database.

 

Table 1. The studies regarding the role of AI in facial recognition in diabetes

Author

(Ref no.)

Year

Area

Findings

Ting (81)

2014

DM identification with the Gabor Filter based on face Block Texture Features

Diagnosis of diabetes with 99.82% accuracy, 99.64% sensitivity, and 100% specificity.

Zhang (82)

2014

Non-Invasive DM detection through facial block color utilizing a Sparse Representation Classifier

Diagnosis of DM with an average accuracy of 97.54%

 

Zhang (83)

2016

Diabetes Identification Using Facial Block Color Features and Sparse Representation Algorithms

With 99.65% sensitivity, 97.93% specificity, and 99.06% accuracy, diabetes is diagnosed.

Padawale

(43)

2016

Diabetes Detection according to Texture and Color Features of Facial Block

94.28% accuracy with k-NN and 97.14% accuracy with SVM classifiers were used to distinguish DM from a healthy patient.

Shu (85)

2017

Evaluation of different Texture Feature extractors for DM Detection in Facial Specific Regions

Diagnosis of diabetes with an accuracy of 99.02%, and sensitivity of 99.64%, as well as specificity rating of 98.26%.

Parvana

(85)

2017

DM detection using the GLCM’s Facial Texture Feature

Diagnosis of DM with 91.67% accuracy, sensitivity of 100% and specificity of 83.33%.

Shu (86)

2018

Non-invasive face block analysis method for detecting diabetes

Through facial key block analysis, the computer-assisted non-invasive diabetes mellitus detection system has demonstrated notable success and efficiency in real-time discrimination between diabetic patients and their healthy counterparts.

Li Zhang (87)

2018

Classification of multiple diseases using facial Image analysis and a Convolutional Neural Network

 

The proposed technique had an average accuracy of 73% based on three datasets that included healthy controls, those with diabetes, and people who had lung disease.

 

Garcia (88)

2019

Features of Facial Texture captured for non-invasive DM detection in a less restrictive environment

SVM-based DM diagnosis with 90% accuracy, 93% sensitivity, and 93% specificity.

 

Zhou (89)

2019

Facial Chromaticity and Texture Features for Non-invasive Disease Detection Using L-SRC

The average accuracy for detecting pre-diabetes was 74.31%. This offers a potential non-invasive screening technique to deal with future diabetes patients.

Zhu (42)

2020

 A Face-based Progressive Stack Network for breast cancer and DM Detection

The results of the experiments indicated that the proposed approach had a 92.94% overall accuracy.

 

Deep Learning Methods
Deep learning is a subset of machine learning that utilizes neural networks with multiple layers to learn from data and make predictions. Unlike traditional machine learning algorithms that require feature extraction and selection by humans, deep learning models automatically learn hierarchical representations of data directly from raw inputs. This capability makes deep learning particularly powerful for tasks involving complex patterns and large datasets (78-80). 
In recent years, CNNs have become pivotal in facial recognition due to their enhanced accuracy. Deep learning, as a broader discipline, shows promise in reducing the influence of emotional variations and varying lighting conditions. Moreover, advanced deep learning algorithms have been developed to analyze video recordings capturing facial movements indicative of certain medical conditions.
Three-dimensional CNNs, an extension of traditional CNNs that process data from consecutive frames, are utilized to detect neurological disorders characterized by facial dysfunctions. Furthermore, cutting-edge deep learning architectures such as Long Short-Term Memory (LSTM) networks have been integrated with conventional classification techniques (45) to further enhance diagnostic capabilities

AI Techniques for Diabetes Diagnosis Using Facial Features
Advancements in AI techniques have facilitated diabetes diagnosis through facial features. However, there have been limited studies conducted on the role of facial recognition in diabetes using AI approaches. Some of the most important ones are mentioned (Table 1). 

Conclusion
Diagnosis of diabetes is achievable through the analysis of facial features using various approaches. While diabetic face recognition can be performed by an experienced physician, the combination of simplicity, accuracy, and cost-effectiveness of AI procedures makes it a promising approach that contributes to advancements in pre-clinical diagnosis.
Recent advancements in AI techniques for diabetes have substantially enhanced the accuracy of facial feature detection. Therefore, it seems that AI-driven facial recognition technology can be instrumental in identifying pre-diabetic individuals. Early identification of pre-diabetes allows for timely interventions, such as lifestyle modifications and medical management, which can delay or even prevent the progression to full-blown diabetes. This approach not only improves patient outcomes but also reduces the economic burden associated with diabetes management and complications.

Funding
None. 

Conflict of Interest
There was no conflict of interest in this manuscript.

 

  1. Rajabi S. Correlation between glycated hemoglobin, serum glucose and serum lipid levels in type 2 diabetes. IJDO 2013; 5(1):1-9.
  2. Baghianimoghadam MH, Afkhami Ardekani M. The effect of educational intervention on quality of life of diabetic patients type 2, referee to diabetic research centre of Yazd. Intern Med Today 2008;13(4):21-8.
  3. Afkhami-Ardekani M, Shojaoddiny-Ardekani A. Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients. Indian J Med Res 2007;126(5):471-4.
  4. Mozaffari-Khosravi H, Jalali-Khanabadi BA, Afkhami-Ardekani M, Fatehi F. The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. J Hum Hypertens 2009 Jan;23(1):48-54. https://pubmed.ncbi.nlm.nih.gov/18685605/
  5. Manaviat MR, Rashidi M, Afkhami-Ardekani M, Shoja MR. Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients. BMC Ophthalmol 2008;8:1-5.
  6. Fatehi F, Malekzadeh G, Akhavi MA, Rashidi M, Afkhami AM. The effect of short message service on knowledge of patients with diabetes in Yazd, Iran. IJDO 2010;2(1):27-31.
  7. Meybodi MA, Afldrami-Ardekani M, Rashidi M. Type 2 Diabetic Patients in Iran. Pak J Biol Sci 2008;11(18):2274-7. https://pubmed.ncbi.nlm.nih.gov/19137840/
  8. Sheikhpour R, Jalali BM. Yaghmaei P, Afkhami M. Effect of two supplementary zinc regimens on serum lipids oxidizability in type II diabetic patients. FEYZ 2009;13(2):103-9.
  9. Zhang P, Zhang B. A study of diabetes mellitus detection using sparse representation algorithms with facial block color features. IEEE Int Confer Signal Image Process (ICSIP) 2016 Aug 13:563-7.
  10. Demayo C, Torres M, Veña C. Face shapes of diabetics and non-diabetics described using geometric morphometrics. Internet J Endocrinol 2009;6(1):1-6. Available at: https://ispub.com/IJEN/6/1/3198
  11. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther 2008;88(11):1254-64. https://pubmed.ncbi.nlm.nih.gov/18801858/
  12. Burgio E, Lopomo A, Migliore L. Obesity and diabetes: from genetics to epigenetics. Mol Biol Rep 2015;42:799-818. https://pubmed.ncbi.nlm.nih.gov/25253098/
  13. Vimaleswaran KS, Loos RJ. Progress in the genetics of common obesity and type 2 diabetes. Expert Rev Mol Med 2010;12:e7. https://pubmed.ncbi.nlm.nih.gov/20184785/
  14. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978;14:141-8. https://pubmed.ncbi.nlm.nih.gov/350680/
  15. Jafar‐Mohammadi B, McCarthy MI. Genetics of type 2 diabetes mellitus and obesity-a review. Ann Med 2008;40(1):2-10. https://pubmed.ncbi.nlm.nih.gov/17952710/
  16. Zhao E, Keller MP, Rabaglia ME, Oler AT, Stapleton DS, Schueler KL, et al. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice. Mamm Genome 2009;20:476-85. https://pubmed.ncbi.nlm.nih.gov/19727952/
  17. Kebede MA, Attie AD. Insights into obesity and diabetes at the intersection of mouse and human genetics. Trends Endocrinol Metab 2014;25(10):493-501. https://pubmed.ncbi.nlm.nih.gov/25034129/
  18. Romao I, Roth J. Genetic and environmental interactions in obesity and type 2 diabetes. J Am Diet Assoc 2008;108(4):S24-8. https://pubmed.ncbi.nlm.nih.gov/18358250/
  19. Joost HG, Schürmann A. The genetic basis of obesity-associated type 2 diabetes (diabesity) in polygenic mouse models. Mamm Genome 2014;25:401-12. https://pubmed.ncbi.nlm.nih.gov/24752583/
  20. Lazar MA. How obesity causes diabetes: not a tall tale. Science 2005 Jan 21;307(5708):373-5. https://pubmed.ncbi.nlm.nih.gov/15662001/
  21. Damcott CM, Sack P, Shuldiner AR. The genetics of obesity. Endocrinol Metab Clin North Am 2003;32(4):761-86. https://pubmed.ncbi.nlm.nih.gov/14711061/
  22. Travers ME, McCarthy MI. Type 2 diabetes and obesity: genomics and the clinic. Hum Genet 2011;130:41-58. https://pubmed.ncbi.nlm.nih.gov/21647602/
  23. Bougneres P. Genetics of obesity and type 2 diabetes: tracking pathogenic traits during the predisease period. Diabetes 2002 Dec:51 Suppl 3:S295-303. https://pubmed.ncbi.nlm.nih.gov/12475766/
  24. Clement K, Boutin P, Froguel P. Genetics of obesity. Am J Pharmacogenomics 2002;2:177-87. https://pubmed.ncbi.nlm.nih.gov/12383024/
  25. Nadler ST, Stoehr JP, Schueler KL, Tanimoto G, Yandell BS, Attie AD. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA 2000;97(21):11371-6. https://pubmed.ncbi.nlm.nih.gov/11027337/
  26. Hauner H. Obesity and diabetes. Textbook of diabetes. 2017:215-28.
  27. McCormack S, Grant SF. Genetics of obesity and type 2 diabetes in African Americans. J Obes 2013:2013:396416. https://pubmed.ncbi.nlm.nih.gov/23577239/
  28. Goodarzi MO. Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications. Lancet Diabetes Endocrinol 2018;6(3):223-36. https://pubmed.ncbi.nlm.nih.gov/28919064/
  29. Hirayama I, Yi Z, Izumi S, Arai I, Suzuki W, Nagamachi Y, et al. Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 1999;48(5):1183-91. https://pubmed.ncbi.nlm.nih.gov/10331427/
  30. Raman R, Rani PK, Gnanamoorthy P, Sudhir RR, Kumaramanikavel G, Sharma T. Association of obesity with diabetic retinopathy: Sankara N ethralaya diabetic retinopathy epidemiology and molecular genetics study (SN-DREAMS Report no. 8). Acta Diabetol 2010;47:209-15. https://pubmed.ncbi.nlm.nih.gov/19326040/
  31. Berumen J, Orozco L, Betancourt-Cravioto M, Gallardo H, Zulueta M, Mendizabal L, et al. Influence of obesity, parental history of diabetes, and genes in type 2 diabetes: a case-control study. Sci Rep 2019;9(1):2748. https://pubmed.ncbi.nlm.nih.gov/30808941/
  32. Barnett AH, Kumar S. Obesity and diabetes. John Wiley & Sons; 2005. 324 p.
  33. Riobó Serván P. Obesity and diabetes. Nutr Hosp 2013 Sep:28 Suppl 5:138-43. https://pubmed.ncbi.nlm.nih.gov/24010754/
  34. Das UN, Rao AA. Gene expression profile in obesity and type 2 diabetes mellitus. Lipids Health Dis 2007;6:1-9. https://pubmed.ncbi.nlm.nih.gov/18078524/
  35. Stoehr JP, Nadler ST, Schueler KL, Rabaglia ME, Yandell BS, Metz SA, et al. Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci. Diabetes 2000;49(11):1946-54. https://pubmed.ncbi.nlm.nih.gov/11078464/
  36. Pillon NJ, Loos RJ, Marshall SM, Zierath JR. Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care. Cell 2021 Mar 18;184(6):1530-44. https://pubmed.ncbi.nlm.nih.gov/33675692/
  37. Schnurr TM, Jakupović H, Carrasquilla GD, Ängquist L, Grarup N, Sørensen TI, et al. Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: a case-cohort study. Diabetologia 2020;63:1324-32. https://pubmed.ncbi.nlm.nih.gov/32291466/
  38. Ling C, Rönn T. Epigenetics in human obesity and type 2 diabetes. Cell Metab 2019;29(5):1028-44. https://pubmed.ncbi.nlm.nih.gov/30982733/
  39. Loos RJ, Yeo GS. The genetics of obesity: from discovery to biology. Nat Rev Genet 2022;23(2):120-33. https://pubmed.ncbi.nlm.nih.gov/34556834/
  40. Herman WH, Ye W, Griffin S, Simmons R, Davies M. Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch study of intensive treatment in people with screen-detected diabetes in primary care (ADDITION-Europe). Diabetes Care 2015;38(8):1449–55. https://pubmed.ncbi.nlm.nih.gov/25986661/
  41. Firdaus AA. Innovation of diabetes mellitus detector based on image processing using the improved patch ordering algorithm. Asia Young Scholars Summit 2019. Available at: https://www.researchgate.net/publication/334653793_INNOVATION_OF_DIABETES_MELLITUS_DETECTOR_BASED_ON_IMAGE_PROCESSING_USING_THE_IMPROVED_PATCH_ORDERING_ALGORITHM.
  42. Zhou J, Zhang Q, Zhang B. A progressive stack face-based network for detecting diabetes mellitus and breast cancer. 2020 IEEE Int Joint Conf Biometr (IJCB) 2020 Sep 28;1-9.
  43. Padawale SN, Jadhav BD. Noninvasive diabetes mellitus detection based on texture and color features of facial block. Int Conf Automat Control Dynamic Optimiz Techniq (ICACDOT) 2016 Sep 9;984-8.
  44. Cheng B, Ma J, Chen X, Yuan L. Objective study of the facial parameters of observations in patients with type 2 diabetes mellitus by machine learning. Ann Transl Med 2022 Sep;10(18):960. https://pubmed.ncbi.nlm.nih.gov/36267751/
  45. Singhal P, Srivastava PK, Tiwari AK, Shukla RK. A survey: approaches to facial detection and recognition with machine learning techniques. Proceed Second Doctoral Symposium Computat Intellig 2022;103-25.
  46. Sheikhpour R. Diabetes and oxidative stress: the mechanism and action. IJDO 2013 Jan 10;5(1):40-5. URL: http://ijdo.ssu.ac.ir/article-1-127-en.html
  47. Kaur P, Krishan K, Sharma SK, Kanchan T. Facial-recognition algorithms: a literature review. Med Sci Law 2020 Apr;60(2):131-9. https://pubmed.ncbi.nlm.nih.gov/31964224/
  48. Loos HS, Wieczorek D, Würtz RP, von der Malsburg C, Horsthemke B. Computer-based recognition of dysmorphic faces. Eur J Hum Genet 2003 Aug;11(8):555-60. https://pubmed.ncbi.nlm.nih.gov/12891374/
  49. Meintjes EM, Douglas TS, Martinez F, Vaughan CL, Adams LP, Stekhoven A, et al. A stereo-photogrammetric method to measure the facial dysmorphology of children in the diagnosis of fetal alcohol syndrome. Med Eng Phys 2002 Dec;24(10):683-9. https://pubmed.ncbi.nlm.nih.gov/12460727/
  50. Wachtman GS, Cohn JF, VanSwearingen JM, Manders EK. Automated tracking of facial features in patients with facial neuromuscular dysfunction. Plast Reconstr Surg 2001 Apr 15;107(5):1124-33. https://pubmed.ncbi.nlm.nih.gov/11373551/
  51. Euprazia LA, Rajeswari A, Thyagharajan KK, Shanker NR. Type 1 and type 2 diabetes measurement using human face skin region. J Diabetes Res 2023 Sep 26;2023:9931010. https://pubmed.ncbi.nlm.nih.gov/37794995/
  52. Tu Y, Quan T. Oxidative stress and human skin connective tissue aging. Cosmetics 2016 Aug 5;3(3):28.
  53. Yan SF, Ramasamy R, Schmidt AM. Mechanisms of disease: advanced glycation end-products and their receptor in inflammation and diabetes complications. Nat Clin Pract Endocrinol Metab 2008 May;4(5):285-93. https://pubmed.ncbi.nlm.nih.gov/18332897/
  54. Yamagishi S, Nakamura N, Suematsu M, Kaseda K, Matsui T. Advanced glycation end products: a molecular target for vascular complications in diabetes. Mol Med 2015 Oct 27;21 Suppl 1:S32-40. https://pubmed.ncbi.nlm.nih.gov/26605646/
  55. Wójcik D, Beń-Skowronek I. Craniofacial morphology in children with growth hormone deficiency and turner syndrome. Diagnostics (Basel) 2020 Feb 7;10(2):88. https://pubmed.ncbi.nlm.nih.gov/32046211/
  56. Al Mushayt A, Al Nwaiser A. Study of craniofacial morphology in children with juvenile diabetes. Egyptian Orthod J 2005 Dec 1;28(December 2005):43-51.
  57. Fitriasari S, Trainor PA. Diabetes, oxidative stress, and DNA damage modulate cranial neural crest cell development and the phenotype variability of craniofacial disorders. Front Cell Dev Biol 2021 May 20;9:644410. https://pubmed.ncbi.nlm.nih.gov/34095113/
  58. Nunes LA, Jesus AS, Casotti CA, Araújo ED. Geometric morphometrics and face shape characteristics associated with chronic disease in the elderly. Bio Sci J 2018:435-46. Available at: https://pesquisa.bvsalud.org/portal/resource/pt/biblio-966692?lang=en
  59. Courtenay LA, González-Aguilera D. Geometric morphometric data augmentation using generative computational learning algorithms. Appl Sci 2020 Dec 21;10(24):9133.
  60. Baab KL, McNulty KP, Rohlf FJ. The shape of human evolution: a geometric morphometrics perspective. Evol Anthropol 2012 Jul-Aug;21(4):151-65. https://pubmed.ncbi.nlm.nih.gov/22907868/
  61. Kemp M, Go YM, Jones DP. Nonequilibrium thermodynamics of thiol/disulfide redox systems: a perspective on redox systems biology. Free Radic Biol Med 2008 Mar 15;44(6):921-37. https://pubmed.ncbi.nlm.nih.gov/18155672/
  62. Magee MF, Bhatt BA. Management of decompensated diabetes. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome. Crit Care Clin 2001 Jan;17(1):75-106. https://pubmed.ncbi.nlm.nih.gov/11219236/
  63. Khan WA, Faisal SS, Hussain SS. Correlation of craniofacial measurements between cephalometric radiographs and facial photographs. ASHKMDC 2018 Mar 31;23(1):37-45.
  64. Naragond A, Kenganal S, Sagarkar R, Kumar N. Diagnostic limitations of cephalometrics in orthodontics-a review. J Dent Med Sci 2012;3(1):30-5.
  65. Sriram RD, Reddy SSK. Artificial intelligence and digital tools: future of diabetes care. Clin Geriatr Med 2020 Aug;36(3):513-25. https://pubmed.ncbi.nlm.nih.gov/32586478/
  66. Doumari SA, Berahmand K, Ebadi MJ. Early and high‐accuracy diagnosis of parkinson’s disease: outcomes of a new model. Computa and Math Meth in Med 2023;2023(1):1493676.
  67. Ghaffar Nia N, Kaplanoglu E, Nasab A. Evaluation of artificial intelligence techniques in disease diagnosis and prediction. Discov Artif Intell 2023 Jan 30;3(1):5.
  68. Wu D, Qiang J, Hong W, Du H, Yang H, Zhu H, et al. Artificial intelligence facial recognition system for diagnosis of endocrine and metabolic syndromes based on a facial image database. Diabetes Metab Syndr 2024 Apr;18(4):103003. https://pubmed.ncbi.nlm.nih.gov/38615568/
  69. Wu D, Chen S, Zhang Y, Zhang H, Wang Q, Li J, et al. Facial recognition intensity in disease diagnosis using automatic facial recognition. J Pers Med 2021 Nov 10;11(11):1172. https://pubmed.ncbi.nlm.nih.gov/34834524/
  70. Chilap P, Chaskar N, Amup V, Pawar AP. Face recognition using machine learning. Haar cascade algorithm and local binary pattern histogram LBPH algorithm in face recognition. IRJEdT. 2022;302. Available at: https://www.irjweb.com/Face%20Recognition%20Using%20Machine%20Learning.pdf
  71. Sinha P, Balas B, Ostrovsky Y, Russell R. Face recognition by humans: nineteen results all computer vision researchers should know about. Proceed IEEE 2006 Nov;94(11):1948-62.
  72. Abdollahi S, Deldari A, Asadi H, Montazerolghaem A, Mazinani SM. Flow-aware forwarding in SDN datacenters using a knapsack-PSO-based solution. IEEE Transac Net Serv Manag 2021 Mar 9;18(3):2902-14.
  73. Sheikhpour R, Sarram MA. Diagnosis of diabetes using an intelligent approach based on bi-level dimensionality reduction and classification algorithms. Iranian J Diab and Obes 2014 Jun 10;6(2):74-84. Available at: https://sid.ir/paper/318188/en
  74. Morales EF, Escalante HJ. A brief introduction to supervised, unsupervised, and reinforcement learning. Biosig Process Classific Comput Learn Intellig 2022 Jan 1;111-29. Academic Press.
  75. Saberi-Movahed F, Rostami M, Berahmand K, Karami S, Tiwari P, Oussalah M, et al. Dual regularized unsupervised feature selection based on matrix factorization and minimum redundancy with application in gene selection. Knowledge-Based Syst 2022 Nov 28;256:109884.
  76. Chen J, Jenkins WK. Facial recognition with PCA and machine learning methods. In2017 IEEE 60th international Midwest symposium on circuits and systems (MWSCAS) 2017 Aug 6 (pp. 973-6). IEEE.
  77. Raju K, Chinna Rao B, Saikumar K, Lakshman Pratap N. A fusion of artificial intelligence and internet of things for emerging cyber system. An optimal hybrid solution to local and global facial recognition through machine learning. 2022;203-26.
  78. Anwarul S, Dahiya S. A comprehensive review on face recognition methods and factors affecting facial recognition accuracy. Proceed ICRIC 2019: Recent Innovat Comput 2020;495-514.
  79. Jayaraman U, Gupta P, Gupta S, Arora G, Tiwari K. Recent development in face recognition. Neurocomputing 2020 Sep 30;408:231-45.
  80. Ghoreyshi ZS, George JT. Quantitative approaches for decoding the specificity of the human T cell repertoire. Front Immunol 2023 Sep 7;14:1228873. https://pubmed.ncbi.nlm.nih.gov/37781387/
  81.  Ting S, Zhang B. Diabetes mellitus detection based on facial block texture features using the Gabor filter. 2014 IEEE 17th Int Conf Comput Sci Engineer 2014 Dec 19;1-6.
  82. Zhang B, Vijaya kumar BV, Zhang D. Noninvasive diabetes mellitus detection using facial block color with a sparse representation classifier. IEEE Trans Biomed Eng 2014 Apr;61(4):1027-33. https://pubmed.ncbi.nlm.nih.gov/24658227/
  83. Zhang P, Zhang B. A study of diabetes mellitus detection using sparse representation algorithms with facial block color features. In 2016 IEEE International Conference on Signal and Image Processing (ICSIP) 2016 Aug 13 (pp. 563-567). IEEE.
  84. Shu T, Zhang B, Yan Tang Y. An extensive analysis of various texture feature extractors to detect Diabetes Mellitus using facial specific regions. Comput Biol Med 2017 Apr 1;83:69-83. https://pubmed.ncbi.nlm.nih.gov/28237906/
  85. Parvana S. Diabetes Mellitus detection based on facial texture feature using the GLCM. Academia 2017;1-9.
  86. Shu T, Zhang B, Tang YY. Computer-assisted non-invasive diabetes mellitus detection system via facial key block analysis. In 2018 International Conference on Wavelet Analysis and Pattern Recognition (ICWAPR) 2018 Jul 15 (pp. 101-106). IEEE.
  87. Zhang L, Zhang B. Non-invasive multi-disease classification via facial image analysis using a convolutional neural network. In 2018 International Conference on Wavelet Analysis and Pattern Recognition (ICWAPR) 2018 Jul 15 (pp. 66-71). IEEE.
  88. Garcia CA, Reyes RS, Abu PA. Non-invasive diabetes detection using facial texture features captured in a less restrictive environment. Int J Recent Technol Eng 2019 Nov 2;8(2S11):3469-73.
  89. Zhou J, Zhang Q, Zhang B. Applying L-SRC for non-invasive disease detection using facial chromaticity and texture features. 2019 IEEE 7th Int Conference Bioinformat Comput Biol (ICBCB) 2019 Mar 21 (pp. 156-61). IEEE.